Compartilhar
Informação da revista
Vol. 39. Núm. 3.Julho - Setembro 2017
Páginas 187-292
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Visitas
1086
Vol. 39. Núm. 3.Julho - Setembro 2017
Páginas 187-292
Letter to the Editor
DOI: 10.1016/j.bjhh.2017.04.003
Assessment of the Matos & Carvalho index for distinguishing thalassemia from iron deficiency anemia
Visitas
1086
Johannes J.M.L. Hoffmanna, Eloísa Urrechagab,
Autor para correspondência
eloisa.urrechagaigartua@osakidetza.net

Corresponding author at: Hematology Laboratory, Hospital Galdakao-Usansolo, 48960 Galdakao, Vizcaya, Spain.
a Global Medical and Scientific Affairs, Abbott Hematology, Hoofddorp, The Netherlands
b Hematology Laboratory, Hospital Galdakao, Galdakao, Spain
Conteúdo relacionado
Rev Bras Hematol Hemoter 2016;38:214-910.1016/j.bjhh.2016.05.011
Januária F. Matos, Luci M.S. Dusse, Karina B.G. Borges, Ricardo L.V. de Castro, Wendel Coura-Vital, Maria das G. Carvalho
Rev Bras Hematol Hemoter 2017;39:290-110.1016/j.bjhh.2017.04.004
Januária F. Matos, Luci M.S. Dusse, Karina B.G. Borges, Ricardo L.V. de Castro, Wendel Coura-Vital, Maria das G. Carvalho
Este item recebeu
1086
Visitas
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Dear Editor,
Texto Completo

In a recent issue of this journal, Matos et al. proposed a new index for discriminating between iron deficiency anemia (IDA) and the thalassemia trait.1 We read their paper with great interest, since we have performed similar research in this field.2 Recently we completed a study in which we compared 25 discriminant formulas incorporating only basic red blood cell (RBC) parameters using a large database of patients with mild microcytic anemia, who either had a diagnosis of IDA or were thalassemia carriers.3 This database now gives us the opportunity to investigate the diagnostic performance of the Matos & Carvalho (M&C) index in a much larger patient cohort than the authors used for their development and validation,1 and we present our findings in this communication.

Our database comprises 2664 patients with microcytic anemia, defined as hemoglobin <13g/dL and mean corpuscular volume (MCV) <80fL, irrespective of gender. It was built over a period of nine years, during which time the Beckman Coulter LH780 was the main hematology analyzer in use; other hematology analyzers were operated for shorter periods. Standard biochemical and hematological methods were used to make the diagnosis; the diagnosis of α-thalassemia was based on molecular techniques. Of our patients, 1196 had “pure” thalassemia (319 α-thalassemia and 877 β-thalassemia), 1259 had simple IDA, 117 had thalassemia with concomitant IDA, 33 had thalassemia with concurrent anemia of chronic disease, 23 had complex thalassemia and 36 had other diseases associated with microcytic anemia.

When applying the M&C formula to our database in the receiver operating characteristic (ROC) analysis, we found an area under the curve (AUC) of 0.892 (95% confidence interval: 0.879–0.904); as Figure 1 demonstrates this AUC is significantly (p-value<0.0001) lower than the three best performing formulas in our study that all had AUCs around 0.95.3 At the optimal cut-off of 23.6, the M&C index resulted in 0.854 sensitivity, 0.795 specificity and a Youden index of 0.649. If we had included the M&C index in our study, then it would have ranked 18 out of the 26 formulas investigated. This is in clear contrast with the findings of Matos et al., who reported excellent diagnostic accuracy of their new index. However, it is not at all unusual for authors of new discriminant indices to overestimate the performance of their invention, as evidenced by independent validation studies.3

Figure 1.
(0,07MB).

Receiver operating characteristic (ROC) analysis of the Matos & Carvalho (M&C) index (black) in comparison with the Janel (green), Green & King (red) and Jayabose (blue) formulas for differentiating iron deficiency anemia from the thalassemia trait.

When considering potential reasons for this disagreement, several factors may play a role. Firstly, Matos et al. derived their index from a population of 106 patients, of whom only 23 had the thalassemia trait. Also their validation group had a small minority of thalassemia carriers, only 16%. In our study group, the proportion of “pure” thalassemia amounted to 45%. Both α- and β-thalassemia have very heterogeneous genetic backgrounds, so this number of thalassemia patients in their study may have been too low to properly characterize the various carrier subtypes; alternatively, the disagreement may be due to local characteristics of the population in the area investigated. Secondly, Matos et al. excluded patients with concomitant IDA and the thalassemia trait; it has been repeatedly demonstrated that this condition causes many discriminant formulas to give an incorrect classification and by excluding this group, they may have introduced a bias in favor of their new index. If we exclude such patients from our analysis, the performance of all discriminant formulas would increase, but this would no longer realistically reflect clinical practice, as approximately 5% of patients with microcytic anemia suffer from IDA associated with the thalassemia trait. Thirdly, the M&C index includes the mean corpuscular hemoglobin concentration (MCHC), a calculated parameter that is known to have relatively weak correlation between different hematology analyzers. Although the type of hematology analyzer was not found to have much impact on the performance of discriminant functions,2 a possible role cannot be excluded. In this context, it is of interest that the MCHC alone has a very poor performance for distinguishing IDA and thalassemia.2

In conclusion, we are unable to confirm the finding by Matos et al. that their new M&C index has excellent performance for discriminating iron deficiency anemia from the thalassemia trait. As a matter of fact, we do not recommend laboratories use any newly published index without additional validation in their own patient population.

Conflicts of interest

Johannes Hoffmann is a scientific employee of Abbott Diagnostics; Eloísa Urrechaga has no conflicts of interest to declare.

References
[1]
J.F. Matos,L.M. Dusse,K.B. Borges,R.L. de Castro,W. Coura-Vital,MdG. Carvalho
A new index to discriminate between iron deficiency anemia and thalassemia trait
Rev Bras Hematol Hemoter, 38 (2016), pp. 214-219 http://dx.doi.org/10.1016/j.bjhh.2016.05.011
[2]
J.J. Hoffmann,E. Urrechaga,U. Aguirre
Discriminant indices for distinguishing thalassemia and iron deficiency in patients with microcytic anemia: a meta-analysis
Clin Chem Lab Med, 53 (2015), pp. 1883-1894 http://dx.doi.org/10.1515/cclm-2015-0179
[3]
E. Urrechaga,J.J. Hoffmann
Critical appraisal of discriminant formulas for distinguishing thalassemia from iron deficiency in patients with microcytic anemia
Clin Chem Lab Med, 55 (2017),
[ahead of print]. Available from: https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2016-0856/cclm-2016-0856.xml?format=INT
Copyright © 2017. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Idiomas
Hematology, Transfusion and Cell Therapy

Receba a nossa Newsletter

Opções de artigo
Ferramentas
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.